Yoga for schizophrenia

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 6, 2013, Pages

  Knowles, Abigail ^a   Chadwick, Jonathan ^a   Vancampfort, Davy ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EVENT; ARTICLE; COMPARATIVE STUDY; HUMAN; MENTAL HEALTH; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; SCHIZOPHRENIA; SOCIAL INTERACTION; SYSTEMATIC REVIEW; TREATMENT RESPONSE; YOGA;

EID: 85041822990     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010554     Document Type: Article

References (39)

1. Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313(7066):1200.
2. Bangalore NG, Varambally S. Yoga therapy for schizophrenia. International Journal of Yoga 2012;5(2):85-91. [PUBMED: 22869990]
3. Bland JM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600.
4. Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, et al.The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use [Apercu sur la problematique des indices d'efficacite therapeutique, 3: comparaison des indices et utilisation. Groupe d'Etude des Indices D'efficacite]. Therapie 1999;54(4):405-11. [PUBMED: 10667106]
5. Bussing A, Michalsen A, Khalsa SBS, Telles S, Sherman KJ. Effects of yoga on mental and physical health: a short summary of reviews. Evidence-Based Complementary and Alternative Medicine 2012 Sep 13 [Epub]. [PUBMED: 23008738]
6. Collins C. Yoga: intuition, preventive medicine, and treatment. Journal of Obstetric, Gynecologic, and Neonatal Nursing 1998;27(5):563-8. [PUBMED: 9773368]
7. Damodaran A, Malathi A, Patil N, Shah N, Suryavansihi, Marathe S. Therapeutic potential of yoga practices in modifying cardiovascular risk profile in middle aged men and women. Journal of the Association of Physicians of India 2002;50(5):633-40. [PUBMED: 12186115]
8. Deeks J. Issues in the selection for meta-analyses of binary data. Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town. Cape Town: The Cochrane Collaboration, 2000.
9. Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7(6):623-9.
10. Donner A, Klar N. Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine 2002;21:2971-80.
11. Duraiswamy G, Thirthalli J, Nagendra HR, Gangadhar BN. Yoga therapy as an add-on treatment in the management of patients with schizophrenia--a randomized controlled trial. Acta Psychiatrica Scandinavica 2007;116(3):226-32. [PUBMED: 17655565]
12. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
13. Elbourne D, Altman DG, Higgins JPT, Curtina F, Worthingtond HV, Vaile A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
14. Feifel D. Is oxytocin a promising treatment for schizophrenia?. Expert Review of Neurotherapeutics 2011; Vol. 11, issue 2:157-9. [PUBMED: 21306203]
15. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology 2006;59(7):7-10.
16. Gulliford MC. Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876-83.
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
18. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
19. Hutton JL. Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials. British Journal of Haematology 2009;146(1):27-30.
20. Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi-Health Systems, 1986.
21. Kern RS, Glynn SM, Horan WP, Marder SR. Psychosocial treatments to promote functional recovery in schizophrenia. Schizophrenia Bulletin 2009;35(2):347-61. [PUBMED: 19176470]
22. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean?. Schizophrenia Research 2005;79(2-3):231-8. [PUBMED: 15982856]
23. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of brief psychiatric rating scale scores. British Journal of Psychiatry 2005;187:366-71. [PUBMED: 16199797]
24. Leucht S, Engel RR, Bauml J, Davis JM. Is the superior efficacy of new generation antipsychotics an artifact of LOCF?. Schizophrenia Bulletin 2007;33(1):183-91. [PUBMED: 16905632]
25. Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249-52.
26. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews 2008;30:67-76. [PUBMED: 18480098]
27. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychological Reports 1962;10:799-812.
28. Ross A, Friedmann E, Bevans M, Thomas S. Frequency of yoga practice predicts health: results of a national survey of yoga practitioners. Evidence-Based Complementary and Alternative Medicine 2012 Sep 13 [Epub]. [PUBMED: 22927885]
29. Rossler W, Salize HJ, van Os J, Riecher-Rossler A. Size of burden of schizophrenia and psychotic disorders. European Neuropsychopharmacology 2005;15(4):399-409. [PUBMED: 15925493]
30. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al.Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008:359-83.
31. Sherman KJ. Guidelines for developing yoga interventions for randomized trials. Evidence-based Complementary and Alternative Medicine 2012 Oct 2 [Epub]. [PUBMED: 23082079]
32. Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future. Schizophrenia Research 2010;122(1-3):1-23. [PUBMED: 20655178]
33. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):1-75.
34. Van Os J, Kapur S. Schizophrenia. Lancet 2009;374(9690):635-45. [PUBMED: 19700006]
35. Vancampfort D, De Hert M, Knapen J, Wampers M, Demunter H, Deckx S, et al.State anxiety, psychological stress and positive well-being responses to yoga and aerobic exercise in people with schizophrenia: a pilot study. Disability and rehabilitation 2011;33(8):684-9. [PUBMED: 20718623]
36. Vancampfort D, Vansteelandt K, Scheewe T, Probst M, Knapen J, De Herdt A, et al.Yoga in schizophrenia: a systematic review of randomised controlled trials. Acta Psychiatrica Scandinavica 2012;126(1):12-20. [PUBMED: 22486714]
37. Varambally S, Gangadhar BN. Yoga: a spiritual practice with therapeutic value in psychiatry. Asian Journal of Psychiatry 2012;5(2):186-9. [PUBMED: 22813667]
38. World Health Organisation. The Global Burden of Disease: 2004 Update. Geneva: World Health Organization, 2008.
39. Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El-Sayeh H, et al.Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin 2009;33(7):254-7.